Assessment of optical coherence tomography angiography and multifocal electroretinography in eyes with and without nonproliferative diabetic retinopathy.


Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
Nov 2021
Historique:
entrez: 28 10 2021
pubmed: 29 10 2021
medline: 5 11 2021
Statut: ppublish

Résumé

To examine (i) the retinal structure and function using optical coherence tomography angiography (OCTA) and multifocal electroretinography (mfERG), respectively, in eyes with and without nonproliferative diabetic retinopathy (NPDR), (ii) and their interrelationship between retinal structure (OCTA) and function (mfERG) in the two groups independently. This was a prospective observational study. One hundred twenty-one eligible participants with type 2 diabetes with No DR (n = 89), or with mild or moderate NPDR (n = 32) underwent ophthalmic examination, ultrawide field-view fundus photography, OCTA, and mfERG. Group differences were assessed using a Mann-Whitney U test. Correlations were assessed using Spearman's rho. There were no significant differences in OCTA measures between the two groups. The mfERG P1 implicit times (rings 1-6) were significantly delayed and P1 response densities in rings 5 and 6 were significantly lower in participants with NPDR compared to those with No DR. In those with No DR, P1 implicit times in almost all rings were delayed in relation to lower vessel density and perfusion (maximum variance noted was 13%). In individuals with NPDR, the P1 response density in rings 2 and 3 showed a positive nonsignificant correlation with macular perfusion. In those with diabetes with No DR, retinal neuronal function is influenced by lower macular vessel density and perfusion. The retinal neuronal function is abnormal in individuals with NPDR compared to those with No DR and is not correlated with OCT angiometric measures, suggesting the likelihood of a different retinal structural correlate.

Identifiants

pubmed: 34708779
pii: IndianJOphthalmol_2021_69_11_3235_329296
doi: 10.4103/ijo.IJO_869_21
pmc: PMC8725080
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

3235-3240

Subventions

Organisme : DBT-Wellcome Trust India Alliance
ID : IA/CPHE/16/1/502670
Pays : India

Déclaration de conflit d'intérêts

None

Références

Br J Ophthalmol. 2000 May;84(5):493-8
pubmed: 10781513
Br J Ophthalmol. 1982 Aug;66(8):492-5
pubmed: 7104265
Ophthalmology. 2003 Sep;110(9):1677-82
pubmed: 13129861
Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):3065-3072
pubmed: 28622398
Diabetologia. 2018 Sep;61(9):1902-1912
pubmed: 30030554
Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):990-998
pubmed: 30884528
Int J Ophthalmol. 2017 Oct 18;10(10):1545-1551
pubmed: 29062774
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2638-51
pubmed: 10509661
J Clin Invest. 1998 Aug 15;102(4):783-91
pubmed: 9710447
Am J Ophthalmol. 2016 Aug;168:129-138
pubmed: 27173374
Doc Ophthalmol. 2008 Nov;117(3):185-9
pubmed: 18324430
Br J Ophthalmol. 2017 Jul;101(7):960-964
pubmed: 27852582
Eye (Lond). 2021 Mar;35(3):858-867
pubmed: 32461566
Prog Retin Eye Res. 2000 Sep;19(5):607-46
pubmed: 10925245
Graefes Arch Clin Exp Ophthalmol. 2019 Jul;257(7):1401-1410
pubmed: 31001668
Prog Retin Eye Res. 2006 Sep;25(5):425-48
pubmed: 16949855
Clin Exp Optom. 2014 Mar;97(2):99-115
pubmed: 23865913
Diabetes. 2017 Sep;66(9):2503-2510
pubmed: 28663190
Retina. 2015 Nov;35(11):2353-63
pubmed: 26465617
Doc Ophthalmol. 2017 Oct;135(2):85-96
pubmed: 28779336
Eye (Lond). 2009 Sep;23(9):1824-30
pubmed: 19648899
J Opt Soc Am A Opt Image Sci Vis. 1996 Mar;13(3):634-40
pubmed: 8627420
Ophthalmology. 1991 May;98(5 Suppl):766-85
pubmed: 2062512
Acta Ophthalmol. 2020 Nov;98(7):e807-e813
pubmed: 32246578
Doc Ophthalmol. 2010 Apr;120(2):193-200
pubmed: 20066472
Invest Ophthalmol Vis Sci. 1996 Apr;37(5):886-97
pubmed: 8603873
Invest Ophthalmol Vis Sci. 2002 May;43(5):1673-85
pubmed: 11980890

Auteurs

Sangeetha Srinivasan (S)

Wellcome Trust/DBT India Alliance, Vision Research Foundation, Chennai, India.

Sobha Sivaprasad (S)

NIHR Moorfields Biomedical Research Centre, London, United Kingdom.

Ramachandran Rajalakshmi (R)

Dr. Mohan's Diabetes Specialties Centre and Madras Diabetes Research Foundation, Chennai, India.

Ranjit M Anjana (RM)

Dr. Mohan's Diabetes Specialties Centre and Madras Diabetes Research Foundation, Chennai, India.

Rayaz A Malik (RA)

Weill Cornell Medicine-Qatar, Education City, Doha, Qatar; Institute of Cardiovascular Medicine, University of Manchester, Manchester, United Kingdom.

Vaitheeswaran Kulothungan (V)

National Centre for Disease Informatics and Research (NCDIR) and Indian Council of Medical Research (ICMR), Bangalore, India.

Rajiv Raman (R)

Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, India.

Muna Bhende (M)

Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH